Y-Intercept »

Oramed Pharm shares owned by Y-Intercept

Quarter-by-quarter ownership of Oramed Pharm (ORMP) shares owned by Y-Intercept from 13F filings

Historical chart of Y-Intercept investment in Oramed Pharm

Tip: Access up to 7 years of quarterly data

All positions including Oramed Pharm held by Y-Intercept consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Oramed Pharm by Y-Intercept

Quarter filed Position value Share count Share price at filing
2026-06-30 $62k 13k 4.81

More positions owned by Y-Intercept

Amazon (AMZN)
Apple (AAPL)
Boston Scientific Corporation (BSX)
Microsoft Corporation (MSFT)
Space Exploration Techn Corp Class A Com Stk (SPCX)
salesforce (CRM)
Cme (CME)
Cognizant Technology Solutio Cl A (CTSH)
Intuit (INTU)
Qualcomm (QCOM)
CBOE Holdings (CBOE)
NVIDIA Corporation (NVDA)
Accenture Plc Ireland Shs Class A (ACN)
Monolithic Power Systems (MPWR)
JPMorgan Chase & Co. (JPM)

View all positions for Y-Intercept

Top funds holding Oramed Pharm

Aquamarine Financial
Mercer Global Advisors
BlackRock
Murchinson
BML Capital Management
Boothbay Fund Management
Geode Capital Management
Goldman Sachs Group
Rathbones Brothers
Vanguard Portfolio Management
Dimensional Fund Advisors
Northern Trust
Renaissance Technologies
Wells Fargo & Company
Bank of America Corporation

View all funds holding Oramed Pharm